EUVIMED · CrossrefJournal
Hematological Oncology
ISSN 0278-0232 · Wiley
Latest articles
Issue Information
Decision‐Making on First‐Line Treatment Alternatives in Chronic Lymphocytic Leukemia: A Multi‐Criteria Decision Analysis to Elicit Stakeholders' Preferences in Italy
Luspatercept in Myelodysplastic Syndromes With Ring Sideroblasts: Long Term Outcome and Impact on Non‐Erythroid Blood Counts
Therapeutic Approaches and Clinical Outcomes of Myeloid/Lymphoid Neoplasms With Eosinophilia Harboring FLT3 Rearrangements: A Systematic Review of 39 Cases
Baseline Spleen Volume is Independently Associated With Survival After CD19‐Directed Chimeric Antigen Receptor T‐Cell Therapy in Relapsed/Refractory Diffuse Large B‐Cell Lymphoma
The Histone Lactylation of KREMEN2 Inhibits Ferroptosis Through the JAK2/STAT3/GPX4 Axis and Promotes the Progression of Mantle Cell Lymphoma
Temporal Trends in Real‐World Outcomes With CPX‐351 in Secondary/High‐Risk Acute Myeloid Leukemia: A PETHEMA Study
Macular OCTA Biomarkers of Ocular Involvement in Patients With Primary Central Nervous System Lymphoma
Extracorporeal Cytokine Hemadsorption for the Treatment of Severe Steroid Refractory Cytokine Release Syndrome Secondary to T‐Cell Immunotherapy for B‐Cell Malignancies: A Case Series
Issue Information
Ibrutinib Dose Adjustment Does Not Impair Treatment Outcome in Mantle Cell Lymphoma: An Italian Real‐Life Multicenter Experience. Results From the REDOT_MCL Study
The Clinical Characteristics and Outcomes of Multiple Myeloma Patients With Oligo or Non–Secretory Relapse—A Retrospective Cohort Study
Zanubrutinib in Hairy Cell Leukemia Variant: Clinical Report and Overview of BTK Inhibition in Variant Disease
Long‐Term Follow‐Up of Chidamide With Chemotherapy in Untreated Peripheral T‐Cell Lymphoma: One Single Center Real‐World Study in China
Sequential BV‐AVD Therapy in Richter Transformation: Insights Into the Management of Elderly Patients
Incidence and Survival of Patients With Angioimmunoblastic T‐Cell Lymphoma: A Nationwide Population‐Based Study Using English Cancer Registration Data
Real‐World Treatment Patterns and Healthcare Resource Utilization of Bruton Tyrosine Kinase Inhibitors for the Treatment of Mantle Cell Lymphoma in the United States
One Grammar, Many Labels: Revisiting the Continuum of Myeloid Neoplasms
RETRACTION: Burkitt Lymphoma Versus Diffuse Large B‐Cell Lymphoma: A Practical Approach
Cutting‐Edge Technologies to Decode Tumor Microenvironment in Multiple Myeloma
Longitudinal Monitoring of Measurable Residual Disease in Chronic Lymphocytic Leukemia Patients Treated With Venetoclax: Results of a Prospective Multicenter Real‐Life Study
Clinical Outcomes of Ruxolitinib Treatment in Patients With IPSS Intermediate‐1‐Risk Myelofibrosis: Interim Analysis From an Italian, Prospective Study (ROMEI)
Efficacy and Safety Comparisons of Four Approved Chimeric Antigen Receptor T‐Cell Therapies in Multiple Myeloma
Anatomical Localization–Based Analysis of Relapsed Secondary Central Nervous System Aggressive B‐Cell Lymphoma (R‐SCNSL)
Outcomes of Bridging Therapy in Patients With Relapsed/Refractory Large B Cell Lymphoma Receiving Third‐Line CAR T
Clinical Outcomes in Double‐Exposed Chronic Lymphocytic Leukemia Patients in Italy
Valemetostat Therapy for Relapsed Adult T‐Cell Leukemia/Lymphoma After Allogeneic Hematopoietic Stem Cell Transplantation
Role of Radiotherapy in the Era of Novel Immune‐Based Treatment Strategies for Multiple Myeloma
Genetic and Transcriptomic Profiles Identify Potential Therapeutic Targets of Concurrent Follicular and Diffuse Large B‐Cell Lymphoma and Transformed Follicular Lymphoma
Identifying Clones in Myelodysplastic Syndromes by Using Single‐Cell RNA Sequencing
Volumes
2026 · 1322025 · 1,0682024 · 1122023 · 8602022 · 1302021 · 5262020 · 1142019 · 6912018 · 1292017 · 6712016 · 382015 · 752014 · 442013 · 722012 · 432011 · 432010 · 322009 · 352008 · 482007 · 322006 · 372005 · 212004 · 182003 · 212002 · 162001 · 292000 · 231999 · 181998 · 341997 · 421996 · 511995 · 421994 · 381993 · 521992 · 541991 · 641990 · 581989 · 681988 · 561987 · 49
EUVIMED